{'fraction_non_alphanumeric': 0.02152317880794702, 'fraction_numerical': 0.013245033112582781, 'mean_word_length': 4.87378640776699, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Attaining target hemoglobin levels in patients new to dialysis: individualizing therapy based on initial hemoglobin levels.

Incident patients on dialysis typically have Hgb levels that are well below the target range of 11 to 12 g/dL as recommended by the NKF-K/DOQI (NKF 2001). Despite a nationwide emphasis on anemia as a quality indicator, low Hgb levels often persist for months after dialysis is initiated. This report provides an overview of an innovative, evidence-based approach to treating anemia that can help shorten the time required to achieve target Hgb levels in patients new to dialysis.